Arthur Hayes, freshly pardoned by US President Donald Trump, has taken a board seat and major stake in a stem cell company where he’s also been a patient.
Arthur Hayes shifts focus to longevity after Trump pardon, invests in stem cell venture
Related posts
Twenty One’s first-day slide highlights investor caution toward BTC-backed stocks
Why Michael Saylor Says Countries Should Launch Bitcoin-Backed Banks
Hate Ticketmaster? Onchain RWA tickets may succeed where regulators haven’t
Bitcoin swings above $94K as crypto faces ‘Netscape’ moment: Finance Redefined
Tether may tokenize equity to ensure liquidity for investors: Report
Figure Technology files ‘second IPO’ to bring native equity issuance to Solana
